about
Norovirus immunology: Of mice and mechanismsNorovirus Regulation by Host and Microbe.Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.Salivary epidermal growth factor correlates with hospitalization length in rotavirus infection.Replication of human noroviruses in stem cell-derived human enteroids.Serum Immunoglobulin A Cross-Strain Blockade of Human NorovirusesSerological Correlates of Protection against a GII.4 Norovirus.Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectivesNorovirus vaccines: Correlates of protection, challenges and limitationsStructural basis for norovirus neutralization by an HBGA blocking human IgA antibodyProgress toward norovirus vaccines: considerations for further development and implementation in potential target populations.Prospects and Challenges in the Development of a Norovirus Vaccine.Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndrome.Epidemiologic, Virologic, and Host Genetic Factors of Norovirus Outbreaks in Long-term Care Facilities.Norovirus-Specific Memory T Cell Responses in Adult Human Donors.Human norovirus infection and the acute serum cytokine response.Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice.The First Norovirus Longitudinal Seroepidemiological Study From Sub-Saharan Africa Reveals High Seroprevalence of Diverse Genotypes Associated With Host Susceptibility Factors
P2860
Q28083087-AC708CDC-F203-469C-A4E8-8EC4FA224F00Q30240631-AA664BC1-167A-4D3E-B896-D0FF278C8420Q30248992-0A85AE58-3512-4D57-B8FB-D53AC4316F29Q30249278-59951B3C-AFEA-4C59-9E67-B3B0B4665524Q30401642-5647AE97-36E6-4AC9-AE4E-D3DF9261EB85Q33654573-6B18C27F-1CD8-4E2C-8ABD-A1B558CC4DEEQ33703664-CE7A23C1-37CF-4949-95C6-3FB8DEB4054EQ33742988-21969AEB-7C26-4626-A23D-C4803F776ECFQ34538562-795F7D4D-74B2-4D1D-88DD-16B0533F25CAQ35837799-2B3B32C1-A15E-4E6F-A02C-287B663F6878Q35901978-37D3EA9A-936F-4C6A-9DCD-F78438663CDBQ35999334-DF89B67B-2B6A-4560-8DA6-10C0CD77249FQ36063949-56E93AAE-78DD-4A3A-8D2E-3D773A841D52Q36275589-93F43FEB-01EF-439F-8F79-F3F176D93941Q37135476-49990737-5052-4BB5-A907-B533FF263177Q37323139-7EB8E583-421D-4369-819A-83FB85C75257Q38557262-27291FD4-33C5-40D8-ACD1-3A7ECD8F177AQ40102851-10B1A2C5-9559-4688-B2DD-379241B3C1CFQ40340737-ADA9215D-20B0-4333-ABCF-C63B16F7E39FQ40385288-1D4EF739-384B-4847-B200-B72304916D21Q40502202-664FD688-AFFC-4A65-A12A-6885C111656FQ41106623-13A7ACA6-895E-4429-88B8-5555BE0C5E26Q54230568-CC517BDB-4D8F-48FC-B172-07624AA0F5EBQ56911160-B8A6A938-C0F2-4EBB-B684-5560AEFFB433
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mucosal and Cellular Immune Responses to Norwalk Virus.
@ast
Mucosal and Cellular Immune Responses to Norwalk Virus.
@en
type
label
Mucosal and Cellular Immune Responses to Norwalk Virus.
@ast
Mucosal and Cellular Immune Responses to Norwalk Virus.
@en
prefLabel
Mucosal and Cellular Immune Responses to Norwalk Virus.
@ast
Mucosal and Cellular Immune Responses to Norwalk Virus.
@en
P2093
P2860
P50
P356
P1476
Mucosal and Cellular Immune Responses to Norwalk Virus.
@en
P2093
Antone R Opekun
Frederick H Neill
Mark A Gilger
Sasirekha Ramani
P2860
P304
P356
10.1093/INFDIS/JIV053
P407
P577
2015-01-29T00:00:00Z